Add to My Stocks
$1.87 $0.04 (2.19%) SRRA stock closing price Sep 19, 2018 (Closing)

The SIERRA ONCOLOGY cash flow statement is one of the important reports considered by investors doing a fundamental analysis of the company. This report provides details about cash inflows and outflows due to the company's business and investment activities, and summarize cash outflows for a given quarter. For SIERRA ONCOLOGY profits one has to check the income statement and for SIERRA ONCOLOGY debt one has to check the balance sheet. SIERRA ONCOLOGY saw a cash impact of $46.13M from the issuance of SRRA shares. The cash flow statement helps in the SIERRA ONCOLOGY stock analysis by providing more information for evaluating changes in assets, liabilities and equities. SRRA decrease in investments stood at a value of $-0.03M for the latest quarter 2018 Q2.

View and download details of SIERRA ONCOLOGY cash flows for latest & last 40 quarters
show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow----------
Net Increase (Decrease) in Assets Liabilities-0.56M-2.65M-0.34M-1.89M-1.47M-1.88M-6.15M--0.12M
Cash From (used in) Discontinued Operations----------
Other Adjustments Net3.11M1.54M5.93M4.52M3.05M1.56M-4.81M3.49M1.37M
Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment-0.03M--0.09M-0.09M-0.08M-0.07M--0.15M-0.18M-0.17M
Acquisition Disposition of Subsidiaires----------
Increase (Decrease) in Investments----------
Other Cash Inflow (Outflow) from Investment Activities----------
Net Cash from (used by) Investment Activities
Issuance (Purchase) of Equity Shares46.13M46.09M27.58M27.44M27.44M27.44M----
Issuance (Repayment) of Debt Securities----------
Increase (Decrease) in Bank & Other Borrowings----------
Payment of Dividends & Other Cash Distributions----------
Other Cash from (used by) Financing Activities--------0.01M-0.01M-0.01M
Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash-0.03M-0.02M------0.05M-0.02M-0.01M
Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year100.54M109M109.01M29.15M2.42M1.31M----
Cash & Equivalents at Year End125.73M134M100.34M107.82M116.69M125.02M-122.68M130.55M140.87M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

While SIERRA ONCOLOGY stock price history provides the price history of a stock, SIERRA ONCOLOGY stock comparison chart shows the same in comparison to peers, and cash flow statements provide cash position of the company. Common terms used in the statement of cash flows are:

  • SIERRA ONCOLOGY has cash of $125.73M on hand. A healthy amount of cash on hand is necessary for any company. Cash has an opportunity cost associated with it, and too much cash in bank may mean that the firm has no or limited growth plans. Hence its important to track the Net Change in Cash and Cash Equivalents along with the SIERRA ONCOLOGY stock price.
  • Cash Flow from operating activities: This is the cash that the company receives from ongoing operations. SIERRA ONCOLOGY lost $-20.88M cash from operations. It is important to check this to see where the company is getting its money from.
  • Cash from investing stood at a negative value of $-0.03M for SRRA stock. A company with surplus cash usually thinks of re-investing it in the form of buying fixed assests, or purchasing plant/ machinery which will help grow the business further. By looking at cash flow from investment activities one can check where the company is putting its cash.
  • Cash flow from financing activities shows the flow of cash between SIERRA ONCOLOGY and its owners and creditors and was $46.13M till 2018 Q2. Financing activities allow a company to raise capital, and repay bondholders.

Key Financial Ratios For SIERRA ONCOLOGY Cash Flow